文献速递细菌感染、耐药与抗菌药物医院感染防控

金黄色葡萄球菌菌血症排除感染性心内膜炎的预测规则比较

Prediction Rules for Ruling Out Endocarditis in Patients With Staphylococcus aureus Bacteremia.
PubMed 文献 · Clin Infect Dis · 2022-01-01

在荷兰7家医院的前瞻性队列中,纳入477例金黄色葡萄球菌菌血症成人患者,比较POSITIVE、PREDICT和VIRSTA评分排除感染性心内膜炎的准确性。VIRSTA评分敏感度98.9%、阴性预测值99.3%,仅其阴性预测值达到预设的至少98%安全阈值,但70.9%患者被归为高风险需经食管超声心动图。

要点

  • VIRSTA评分阴性预测值99.3%,达到至少98%的安全排除阈值。
  • POSITIVE和PREDICT评分阴性预测值分别为92.5%和94.5%,未达安全阈值。
  • VIRSTA将70.9%患者归为高风险,需经食管超声心动图。

核心结论

  • 仅VIRSTA评分阴性预测值达到至少98%,可安全排除感染性心内膜炎,但代价是大量患者被归为高风险需经食管超声心动图。

研究设计与样本

  • 2017年8月至2019年9月荷兰7家医院的前瞻性队列研究,连续纳入477例成人金黄色葡萄球菌菌血症患者。
  • 以改良Duke标准确诊感染性心内膜炎为参考标准,计算POSITIVE、PREDICT和VIRSTA评分的敏感度、特异度、阴性预测值和阳性预测值。

主要发现

  • 477例中87例(18.2%)确诊感染性心内膜炎,87%患者接受超声心动图,42%接受经食管超声心动图。
  • POSITIVE(n=362)、PREDICT和VIRSTA评分的敏感度分别为77.6%(65.8%-86.9%)、85.1%(75.8%-91.8%)和98.9%(95.7%-100%)。
  • POSITIVE、PREDICT和VIRSTA评分的阴性预测值分别为92.5%(87.9%-95.8%)、94.5%(90.7%-97.0%)和99.3%(94.9%-100%)。
  • POSITIVE、PREDICT和VIRSTA评分将分别44.5%、50.7%和70.9%的患者归为感染性心内膜炎高风险。

关键数值与推荐

  • 阴性预测值至少98%被视为可安全排除感染性心内膜炎的阈值。
  • VIRSTA评分敏感度98.9%、阴性预测值99.3%,达到安全排除阈值。

临床怎么用

  • 对金黄色葡萄球菌菌血症患者,VIRSTA评分阴性预测值达99.3%,可用于筛选可安全排除感染性心内膜炎的患者。
  • 使用VIRSTA评分需注意其将70.9%患者归为高风险,可能导致较多经食管超声心动图检查。

局限性

  • 研究仅在荷兰7家医院进行,外推性需进一步验证。
  • POSITIVE评分仅362例可评估,样本量少于其他评分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Staphylococcus aureus bacteremia (SAB) is in 10% to 20% of cases complicated by infective endocarditis. Clinical prediction scores may select patients with SAB at highest risk for endocarditis, improving the diagnostic process of endocarditis. We compared the accuracy of the Prediction Of Staphylococcus aureus Infective endocarditiseTime to positivity, Iv drug use, Vascular phenomena, preExisting heart condition (POSITIVE), Predicting Risk of Endocarditis Using a Clinical Tool (PREDICT), and VIRSTA scores for classifying the likelihood of endocarditis in patients with SAB. METHODS: Between August 2017 and September 2019, we enrolled consecutive adult patients with SAB in a prospective cohort study in 7 hospitals in the Netherlands. Using the modified Duke Criteria for definite endocarditis as reference standard, sensitivity, specificity, negative predictive (NPV), and positive predictive values were determined for the POSITIVE, PREDICT, and VIRSTA scores. An NPV of at least 98% was considered safe for excluding endocarditis. RESULTS: Of 477 SAB patients enrolled, 33% had community-acquired SAB, 8% had a prosthetic valve, and 11% a cardiac implantable electronic device. Echocardiography was performed in 87% of patients, and 42% received transesophageal echocardiography (TEE). Eighty-seven (18.2%) had definite endocarditis. Sensitivity was 77.6% (65.8%-86.9%), 85.1% (75.8%-91.8%), and 98.9% (95.7%-100%) for the POSITIVE (n = 362), PREDICT, and VIRSTA scores, respectively. NPVs were 92.5% (87.9%-95.8%), 94.5% (90.7%-97.0%), and 99.3% (94.9%-100%). For the POSITIVE, PREDICT, and VIRSTA scores, 44.5%, 50.7%, and 70.9% of patients with SAB, respectively, were classified as at high risk for endocarditis. CONCLUSIONS: Only the VIRSTA score had an NPV of at least 98%, but at the expense of a high number of patients classified as high risk and thus requiring TEE. CLINICAL TRIALS REGISTRATION: Netherlands Trial Register code 6669.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. van der Vaart TW, Prins JM, Soetekouw R, et al. Prediction Rules for Ruling Out Endocarditis in Patients With Staphylococcus aureus Bacteremia. Clin Infect Dis. 2022. PMID: 34272564. doi:10.1093/cid/ciab632

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。